REFERENCES
1. Pournaras DJ, Photi ES, Barnett N, et al. Assessing the quality of primary care referrals to surgery of patients with diabetes in the East of England: a multi-centre cross-sectional cohort study. Int J Clin Pract. 2017;71:e12971.
2. Meneghini LF. Perioperative management of diabetes: translating evidence into practice. Cleve Clin J Med. 2009;76 Suppl 4:S53-9.
4. Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53:2079-86.
5. Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care. 2013;17:305.
6. Finfer S, Chittock DR, Su SY, et al. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-97.
7. Fabbri A, Marchesini G, Benazzi B, et al. Stress hyperglycemia and mortality in subjects with diabetes and sepsis. Crit Care Explor. 2020;2:e0152.
8. Roberts GW, Quinn SJ, Valentine N, et al. Relative hyperglycemia, a marker of critical Illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100:4490-7.
9. International Diabetes Federation. IDF atlas, 10th edition 2021. Available from: https://www.diabetesatlas.org/ [Last accessed on 1 Sep 2022].
10. Dhatariya KK. Why the definitions used to diagnose diabetic ketoacidosis should be standardised. Diabetes Res Clin Pract. 2018;135:227-8.
11. Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg. 2013;257:8-14.
12. Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33:1783-8.
13. Rawshani A, Rawshani A, Franzén S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379:633-44.
14. Centre for Perioperative Care. Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency surgery, 2021. Available from: https://diabetes-resources-production.s3.eu-west-1.amazonaws.com/resources-s3/public/2021-03/CPOC-Diabetes-Guideline2021.pdf [Last accessed on 1 Sep 2022].
15. Gillis C, Ljungqvist O, Carli F. Prehabilitation, enhanced recovery after surgery, or both? Br J Anaesth. 2022;128:434-48.
16. Levy N, Dhatariya K. Pre-operative optimisation of the surgical patient with diagnosed and undiagnosed diabetes: a practical review. Anaesthesia. 2019;74 Suppl 1:58-66.
17. Rollins KE, Varadhan KK, Dhatariya K, Lobo DN. Systematic review of the impact of HbA1c on outcomes following surgery in patients with diabetes mellitus. Clin Nutr. 2016;35:308-16.
18. Wang J, Luo X, Jin X, et al. Effects of preoperative HbA1c levels on the postoperative outcomes of coronary artery disease surgical treatment in patients with diabetes mellitus and nondiabetic patients: a systematic review and meta-analysis. J Diabetes Res. 2020;2020:3547491.
19. National Institute for Health and Care Excellence. Routine preoperative tests for elective surgery (NG45) 2016. Available from: https://www.nice.org.uk/guidance/ng45 [Last accessed on 1 Sep 2022].
20. Garg R, Schuman B, Bader A, et al. Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery. Ann Surg. 2018;267:858-62.
21. Juray S, Axen KV, Trasino SE. Remission of type 2 diabetes with very low-calorie diets-a narrative review. Nutrients. 2021;13:2086.
22. Kempf K, Röhling M, Banzer W, et al. High-Protein, Low-glycaemic meal replacement decreases fasting insulin and inflammation markers-a 12-month subanalysis of the ACOORH trial. Nutrients. 2021;13:1433.
23. Pournaras DJ, Nygren J, Hagström-Toft E, Arner P, le Roux CW, Thorell A. Improved glucose metabolism after gastric bypass: evolution of the paradigm. Surg Obes Relat Dis. 2016;12:1457-65.
24. Colles SL, Dixon JB, Marks P, Strauss BJ, O'Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84:304-11.
25. Ross LJ, Wallin S, Osland EJ, Memon MA. Commercial very low energy meal replacements for preoperative weight loss in obese patients: a systematic review. Obes Surg. 2016;26:1343-51.
26. Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022;10:284-96.
27. Griffin SB, Ross LJ, Burstow MJ, Desbrow B, Palmer MA. Efficacy of a dietitian-led very low calorie diet (VLCD) based model of care to facilitate weight loss for obese patients prior to elective, non-bariatric surgery. J Hum Nutr Diet. 2021;34:188-98.
28. Ruggenenti P, Abbate M, Ruggiero B, et al. C. RE.S.O. Study Group. Renal and systemic effects of calorie restriction in patients with type 2 diabetes with abdominal obesity: a randomized controlled trial. Diabetes. 2017;66:75-86.
29. Holt RIG, Barnard-Kelly K, Dritsakis G, et al. OCTOPuS study group. Developing an intervention to optimise the outcome of cardiac surgery in people with diabetes: the OCTOPuS pilot study. Pilot Feasibility Stud. 2021;7:157.
30. Li S, Vandvik PO, Lytvyn L, et al. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline. BMJ. 2021;373:n1091.
31. Houlden RL, Yen JL, Moore S. Effectiveness of an interprofessional glycemic optimization clinic on preoperative glycated hemoglobin levels for adult patients with type 2 diabetes undergoing bariatric surgery. Can J Diabetes. 2018;42:514-9.
32. Frías JP, Davies MJ, Rosenstock J, et al. SURPASS-2 Investigators. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385:503-15.
33. Jastreboff AM, Aronne LJ, Ahmad NN, et al. SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205-16.
34. Rubino F, Nathan DM, Eckel RH, et al. Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis. 2016;12:1144-62.
35. Lee Y, Dang JT, Switzer N, Malhan R, Birch DW, Karmali S. Bridging interventions before bariatric surgery in patients with BMI ≥ 50 kg/m2: a systematic review and meta-analysis. Surg Endosc. 2019;33:3578-88.
36. Kotinda APST, de Moura DTH, Ribeiro IB, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020;30:2743-53.
37. Abu Dayyeh BK, Maselli DB, Rapaka B, et al. Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Lancet. 2021;398:1965-73.
38. Zorron R, Veltzke-Schlieker W, Adler A, et al. Endoscopic sleeve gastroplasty using Apollo Overstitch as a bridging procedure for superobese and high risk patients. Endoscopy. 2018;50:81-3.
39. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022;400:441-51.
40. Albaugh VL, Sharma G, Tu C, Aminian A. Clinical significance of diabetes control before metabolic surgery. Surg Obes Relat Dis. 2021;17:1271-8.
41. Umpierrez G, Cardona S, Pasquel F, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care. 2015;38:1665-72.
42. Cardona S, Tsegka K, Pasquel FJ, et al. Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery. BMJ Open Diabetes Res Care. 2019;7:e000703.
43. van den Boom W, Schroeder RA, Manning MW, Setji TL, Fiestan GO, Dunson DB. Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care. 2018;41:782-8.
44. Chiang HY, Lin KR, Hsiao YL, et al. Association between preoperative blood glucose level and hospital length of stay for patients undergoing appendectomy or laparoscopic cholecystectomy. Diabetes Care. 2021;44:107-15.
45. He T, Zhu W, Wang C, et al. Relationship between pre-operative blood glucose level and length of hospital stay in patients with renal cell carcinoma undergoing laparoscopic nephrectomy. Front Surg. 2021;8:659365.
46. Domek N, Dux K, Pinzur M, Weaver F, Rogers T. Association between hemoglobin a1c and surgical morbidity in elective foot and ankle surgery. J Foot Ankle Surg. 2016;55:939-43.
47. Gustafsson UO, Thorell A, Soop M, Ljungqvist O, Nygren J. Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. Br J Surg. 2009;96:1358-64.
48. O'Sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006;32:188-97.
49. Vilar-Compte D, Alvarez de Iturbe I, Martín-Onraet A, Pérez-Amador M, Sánchez-Hernández C, Volkow P. Hyperglycemia as a risk factor for surgical site infections in patients undergoing mastectomy. Am J Infect Control. 2008;36:192-8.
50. Makino H, Tanaka A, Asakura K, et al. Addition of low-dose liraglutide to insulin therapy is useful for glycaemic control during the peri-operative period: effect of glucagon-like peptide-1 receptor agonist therapy on glycaemic control in patients undergoing cardiac surgery (GLOLIA study). Diabet Med. 2019;36:1621-8.
51. Hulst AH, Visscher MJ, Godfried MB, et al. GLOBE Study Group. Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial. Diabetes Obes Metab. 2020;22:557-65.
52. Kaneko S, Ueda Y, Tahara Y. GLP1 receptor agonist liraglutide is an effective therapeutic option for perioperative glycemic control in type 2 diabetes within Enhanced Recovery After Surgery (ERAS) protocols. Eur Surg Res. 2018;59:349-60.
53. Draznin B, Aroda VR, Bakris G, et al. American Diabetes Association Professional Practice Committee. , American Diabetes Association Professional Practice Committee:. 16. Diabetes care in the hospital: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S244-53.
54. Duggan E, Chen Y. Glycemic management in the operating room: screening, monitoring, oral hypoglycemics, and insulin therapy. Curr Diab Rep. 2019;19:134.
55. Clinical Pharmacy Association. Perioperative Handbook 2022. Available from: https://www.ukcpa-periophandbook.co.uk/ [Last accessed on 1 Sep 2022].
